'This Isn't The Past Novartis,' Jimenez Tells JPM Conference
This article was originally published in Scrip
Novartis AG is making faster decisions. That's the message CEO Joseph Jimenez wanted investors at the JP Morgan Healthcare conference Jan. 11 to take away. He vowed the company would not spend years investing to turn around its Alcon eye care business before making a decision about considering alternative options for the unit.
Register for our free email digests: